Public Profile

GILUPI GmbH

GILUPI GmbH, headquartered in Germany, is a pioneering company in the field of medical technology, specialising in innovative solutions for cancer diagnostics. Founded in 2006, GILUPI has made significant strides in the industry, particularly with its flagship product, the GILUPI CellCollector, which enables the capture of circulating tumour cells (CTCs) from blood samples. This unique technology enhances early cancer detection and monitoring, setting GILUPI apart in the competitive landscape of oncology diagnostics. With a strong presence in Europe and expanding operations globally, GILUPI is recognised for its commitment to advancing personalised medicine. The company has achieved notable milestones, including collaborations with leading research institutions, further solidifying its position as a key player in the medical technology sector. GILUPI continues to drive innovation, aiming to improve patient outcomes through its cutting-edge diagnostic solutions.

DitchCarbon Score

How does GILUPI GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

15

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

GILUPI GmbH's score of 15 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.

21%

Let us know if this data was useful to you

GILUPI GmbH's reported carbon emissions

GILUPI GmbH, headquartered in Germany, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed emissions data, it is essential to monitor GILUPI's future initiatives and commitments to understand its role in sustainability and climate responsibility within the industry.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. GILUPI GmbH's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for GILUPI GmbH is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

GILUPI GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Guardant Health

US
Research and development services (73)
Updated about 2 hours ago

Celsee, Inc.

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 months ago
DitchCarbon Score

Biolidics Limited

SG
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

OncoDNA SA

BE
Other business services (74)
Updated 1 day ago

ANGLE plc

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers